OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thematic Analysis of State Medicaid Buprenorphine Prior Authorization Requirements
Max Jordan Nguemeni Tiako, Abby Dolan, Matthew P. Abrams, et al.
JAMA Network Open (2023) Vol. 6, Iss. 6, pp. e2318487-e2318487
Open Access | Times Cited: 14

Showing 14 citing articles:

Treatment for Opioid Use Disorder: Population Estimates — United States, 2022
Deborah Dowell, Samantha M. Brown, Shiromani Gyawali, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 25, pp. 567-574
Open Access | Times Cited: 45

Racial, Ethnic, and Gender Diversity Among Academic Surgical Leaders in the US
Yoshiko Iwai, Alice Yunzi L. Yu, Nikki C. Daniels, et al.
JAMA Surgery (2023) Vol. 158, Iss. 12, pp. 1328-1328
Closed Access | Times Cited: 25

The association between buprenorphine doses above 16 milligrams and treatment retention in a multi‐payer national sample in the United States, 2014 to 2021
Erin J. Stringfellow, Huiru Dong, Seyedeh Nazanin Khatami, et al.
Addiction (2025)
Closed Access | Times Cited: 1

Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims
Kevin Y. Xu, Alex K. Gertner, Shelly F. Greenfield, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8

Real-world access to buprenorphine treatment in Philadelphia: A secret shopper study
Margaret Lowenstein, M Holliday Davis, Shoshana V. Aronowitz, et al.
Drug and Alcohol Dependence (2025) Vol. 268, pp. 112586-112586
Closed Access

How Do I Manage My Patients’ Constant Need for Prior Authorizations or Out-of-Pocket Medication Costs?
Shirley Johnson, Austin Hardy, Benjamin Jaworowski, et al.
Oxford University Press eBooks (2025), pp. 283-294
Closed Access

Buprenorphine adherence among a prospective cohort of homeless-experienced adults with opioid use disorder
Danielle R. Fine, Natalia Critchley, Katherine Hart, et al.
Drug and Alcohol Dependence (2025) Vol. 270, pp. 112598-112598
Closed Access

Unrestricted insurance coverage of buprenorphine formulations remains sparse in comparison to conventional opioids
Bennett Andrassy, Junaid Mukhdomi, Nidhi Bhaskar, et al.
Regional Anesthesia & Pain Medicine (2025), pp. rapm-106306
Closed Access

Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl
Bradley D. Stein, Flora Sheng, Brendan Saloner, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access

Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization
Sarah Axeen, Rosalie Liccardo Pacula, Jessica S. Merlin, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2435478-e2435478
Open Access | Times Cited: 3

Perceptions of structural and provider-based substance use stigma interventions among primary care professionals
Erin Fanning Madden, Felicia Frabis, Jonathan Cohn, et al.
Drug and Alcohol Dependence Reports (2024) Vol. 12, pp. 100259-100259
Open Access | Times Cited: 2

Dosing Inequities in Opioid Use Disorder Treatment Trials
Davida M. Schiff, Nichole Nidey, Max Jordan Nguemeni Tiako
JAMA Network Open (2024) Vol. 7, Iss. 10, pp. e2436582-e2436582
Open Access | Times Cited: 1

Page 1

Scroll to top